Home/Filings/4/0001415889-25-006552
4//SEC Filing

CHURCH KEVIN 4

Accession 0001415889-25-006552

CIK 0001620463other

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 4:30 PM ET

Size

8.2 KB

Accession

0001415889-25-006552

Insider Transaction Report

Form 4
Period: 2025-03-03
CHURCH KEVIN
CHIEF SCIENTIFIC OFFICER
Transactions
  • Award

    Restricted Stock Units

    2025-03-03+58,56358,563 total
    Common Stock (58,563 underlying)
  • Award

    Stock Option (Right to Buy)

    2025-03-03+87,84587,845 total
    Exercise: $0.38Exp: 2035-03-02Common Stock (87,845 underlying)
Footnotes (3)
  • [F1]The shares subject to the option shall be scheduled to vest monthly over a term of 48 months on the monthly anniversaries of the grant date, subject to the optionee continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan) through the applicable vesting dates.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one (1) share of Issuer's common stock.
  • [F3]100% of the RSUs shall vest on the one (1) year anniversary of the grant date, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2020 Equity Incentive Plan (the "Plan")) through the vesting date.

Issuer

Athira Pharma, Inc.

CIK 0001620463

Entity typeother

Related Parties

1
  • filerCIK 0001822499

Filing Metadata

Form type
4
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:30 PM ET
Size
8.2 KB